Janet Kukreja, MD
Associate Professor, Surgery-Urology
Medical School
- MD, University of Missouri-Kansas City School of Medicine (2010)
Graduate School
- MPH, University of Rochester (2014)
Undergraduate School
- BA, University of Missouri–Kansas City (MO) (2009)
Residency
- University of Rochester Program, Chief Resident, Urology (2016)
Fellowships
- University of Texas at Houston/M D Anderson Cancer Center Program, Urologic Oncology (2018)
Languages
EnglishDepartment
Surgery-UrologyProfessional Titles
- Urologic Oncologist
- Director of Urologic Oncology
Recognitions
- John Quale Travel Fellowship, Bladder Cancer Advocacy Network (2017)
- Outstanding Laparoendoscopic Resident Award, Society for Laparoendoscopic Surgeons (2017)
- Medical Staff Quality Improvement Award, University of Colorado Hospital (2021)
Research Interests
Bladder CancerPublications
- Welliver C, MacLachlan LS, Riggs S, Kukreja JB, Miles-Thomas J. A Multifaceted Assessment of Benign Prostatic Hyperplasia Practice and AUA Guideline Adherence. Urol Pract. 2024 Nov;11(6):950-955. PubMed PMID: 39196671
- Wiesen B, Atwell M, Leavitt C, Clark N, Kessler E, Lam E, Flaig T, Kukreja J, Kim S, Maroni P, Cost NG. Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer. JCO Oncol Pract. 2024 Mar;20(3):361-369. PubMed PMID: 38127812
- Kukreja JB. Non-muscle-invasive Bladder Cancer: Side-by-Side Guideline Comparison. Eur Urol Focus. 2023 Nov;9(6):954-956. PubMed PMID: 37308343
- Wiesen B, Atwell M, Leavitt C, Clark N, Kessler E, Lam E, Flaig T, Kukreja J, Kim S, Maroni P, Cost NG. Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer. JCO Oncol Pract. 2023 Dec 21;:OP2300580. [Epub ahead of print] PubMed PMID: 38127812
- Kukreja JB. Non-muscle-invasive Bladder Cancer: Side-by-Side Guideline Comparison. Eur Urol Focus. 2023 Nov;9(6):954-956. PubMed PMID: 37308343
Professional Memberships
- American College of Surgeons, Member
- International Bladder Cancer Network, Member
- American Urologic Association, Member
- Society of Urologic Oncology, Member
- Southwestern Oncology Group (SWOG), Investigator
- Rocky Mountain Urologic Society, Member
- Society of Women in Urology, Member
- Institute for healthcare, quality, safety and efficiency, Faculty
- South Centeral Section of the AUA, Member
Practice Locations
UCHealth Tony Grampsas Urologic Cancer Care Clinic - Anschutz Medical Campus1665 Aurora Ct
1st Floor
Aurora, CO 80045
720-848-0170
Hospital Affiliation
- University of Colorado Hospital
- Denver Health Medical Center
- Veterans Affairs Medical Center
- UCHealth Highlands Ranch Hospital
Center Affiliations
Specialty Information
Specialties- Urology, Board Certification (2020, 2020)
- Urologic Oncology, Board Certification
- Urologic Oncology, Certificate (2018)
- Cancers - Bladder Cancer
- Cancers
- Cancers - Cancer Surgery
- Cancers - Chemotherapy
- Cancers - Kidney Cancer
- Cancers - Prostate Cancer
- Cancers - Testicular Cancer
- Cancers - Urologic Cancer
- Surgery
- Surgery - Robotic Surgery
- Surgery - Urologic Surgery
- Failed Prior Surgery
- Kidneys and Urinary System
- Kidneys and Urinary System - Bladder Disease
Clinical Interests
Dr. Kukreja particular interest in the treatment of urologic cancers and focuses on bladder cancer for research. She believes in providing the most advanced therapies and technology and care for patients with urologic cancers. She has a special interest in perioperative care. She offers the following procedures robotic bladder (cystectomy/cystoprostatectomy) also known as a robotic cystectomy and urinary diversion creation (Ileal conduit, Indiana Pouch and Neobladder. She also offers robotic removal of: adrenal glands, prostate (prostatectomy), kidney (nephrectomy), partial kidney (partial nephrectomy/nephron sparing surgery), minimally invasive surgery, retroperitoneal lymph node dissection, inguinal lymph node removal, ureteral removal (partial ureterectomy).
Care Philosophy
Dr. Kukreja is the Director of Urological Oncology. She believes in providing the best care for urological cancer patients. This includes a multidisciplinary approach as well as the most advanced technology. Working with patients in developing a treatment plan is extremely important in the treatment of urologic cancers. Patients with urologic cancers often have unique needs and these must be recognized. She hopes that through the latest developments in surgery and cancer care we can provide the best urologic cancer care. Dr. Kukreja has performed over 500 robotic cystectomies and performs about 150 robot assisted bladder removal cases per year (radical cystectomies). Dr. Kukreja believes that having a physician that performs many of the same procedures per year improves outcomes and decreases complications. Dr. Kukreja performs the urinary diversions inside of the body with the robot and without making a larger incision. She does equal ileal conduits and neobladders every year.
Dr. Kukreja particular interest in the treatment of urologic cancers and focuses on bladder cancer for research. She believes in providing the most advanced therapies and technology and care for patients with urologic cancers. She has a special interest in perioperative care. She offers the following procedures robotic bladder (cystectomy/cystoprostatectomy) also known as a robotic cystectomy and urinary diversion creation (Ileal conduit, Indiana Pouch and Neobladder. She also offers robotic removal of: adrenal glands, prostate (prostatectomy), kidney (nephrectomy), partial kidney (partial nephrectomy/nephron sparing surgery), minimally invasive surgery, retroperitoneal lymph node dissection, inguinal lymph node removal, ureteral removal (partial ureterectomy).
Care Philosophy
Dr. Kukreja is the Director of Urological Oncology. She believes in providing the best care for urological cancer patients. This includes a multidisciplinary approach as well as the most advanced technology. Working with patients in developing a treatment plan is extremely important in the treatment of urologic cancers. Patients with urologic cancers often have unique needs and these must be recognized. She hopes that through the latest developments in surgery and cancer care we can provide the best urologic cancer care. Dr. Kukreja has performed over 500 robotic cystectomies and performs about 150 robot assisted bladder removal cases per year (radical cystectomies). Dr. Kukreja believes that having a physician that performs many of the same procedures per year improves outcomes and decreases complications. Dr. Kukreja performs the urinary diversions inside of the body with the robot and without making a larger incision. She does equal ileal conduits and neobladders every year.
Personal Interests
I am very passionate about all urologic cancers, specifically bladder cancer. I have a particular interest in perioperative care for all cancer patients.
Public Speaking
Yes
I speak often about bladder cancer, surgery for bladder cancer and perioperative care for bladder cancer.
I am very passionate about all urologic cancers, specifically bladder cancer. I have a particular interest in perioperative care for all cancer patients.
Public Speaking
Yes
I speak often about bladder cancer, surgery for bladder cancer and perioperative care for bladder cancer.